ltthermascan inc receives fda approval on drug new york oct thermascan inc said the us food and drug administration has approved clinical trials of a new advanced aids confirmation test developed by the company thermascan said that about trials will be taken on the the new test called fluorognost in the next three months through blood banks hospitals and health centers as well as by individual physicians the trials will be conducted in new york at the beth israel medical centre the sacremento medical foundation blood center the karolinska institute stockholm and the institute of hygiene at the university of innspruck reuter